Abstract:BACKGROUND: With the progress of the mid-term and long-term follow-up study, it is found that the periprosthesis loosening is an important factor that limits the service life of artificial prosthesis and restricts the development of artificial joint replacement. OBJECTIVE: To further understand the Wnt/β-catenin signaling pathway and provide new targets for drug therapy by analyzing the research results of main signal factors of Wnt/β-catenin signaling pathway on osteoblasts and the cell function of osteoblast origin. METHODS: The first author searched the literature published from 2005 to 2020 by computer with the Chinese key words of “wear debris, peri-prosthetic osteolysis, aseptic loosening, pathogenesis, osteoblast, signaling pathway, bone remodeling, Wnt/β-catenin” in the databases of CNKI, Wanfang and VIP, and with the English key words of “wear debris, wear particles, peri-prosthetic osteolysis, PPO, aseptic loosening, AL, pathogenesis, osteoblast, OB, signal path, bone remodeling, Wnt/β-catenin” in PubMed and Web of Science. The articles regarding the effect and mechanism of Wnt/β-catenin pathway on osteoblasts under the influence of wear particles were collected. Finally, 53 articles were included according to the inclusion and exclusion criteria. RESULTS AND CONCLUSION: (1) During the pathological process of wear particle induced osteolysis around implant and aseptic loosening, Wnt/β-catenin signaling pathways activated by inhibiting bone-forming formation and increasing bone resorption, in turn, affects bone reconstruction, and has played a key role in the pathology of wear particle induced osteolysis around implant and aseptic loosening. (2) In vitro experiments, Wnt/β-catenin signaling pathways were activated by GSK-3β inhibitor LiCl, growth hormone release polypeptide, and protein phosphatase 2A inhibition to promote osteoblast differentiation and osteogenic activity. However, ICG-001 inhibitor blocked the β-catenin signaling pathway, thus weakening the protective effect of LiCl on osteoblastic differentiation, suggesting that GSK-3/β-catenin signaling pathway may be an important mechanism mediating Ti wear particles to induce osteolysis around the prosthesis. (3) In vivo experiments, the application of SOST antibody, protein phosphatase 2A inhibition, LiCl, AR28 and other ways through activation of Wnt/β-catenin and other signal pathways can promote bone formation, inhibit osteoclast absorption, increase local bone mass and bone volume, and resist the effect of osteolysis around the prosthesis induced by Ti and other wear particles. (4) At the gene level, the activity and mineralization of MC3T3-E1 cells were also significantly enhanced under SOST silencing condition, even when treated with titanium particles. On the contrary, the decreased expression level of SOST increased the expression level of β-catenin. The results suggested that the decrease of SOST gene expression could activate the Wnt/β-catenin signaling pathway to promote bone formation and improve the bone loss caused by Ti particles.

Nanoscale ZnO doping in prosthetic polymers mitigate wear particle-induced inflammation and osteolysis through inhibiting macrophage secretory autophagy

Is there another possible approach to inhibit wear particles-induced inflammatory osteolysis?

TiAl6V4 Particles Promote Osteoclast Formation Via Autophagy-Mediated Downregulation of Interferon-Beta in Osteocytes

Autophagy Mediated CoCrMo Particle-Induced Peri-Implant Osteolysis by Promoting Osteoblast Apoptosis.

Nanosized Alumina Particle and Proteasome Inhibitor Bortezomib Prevented inflammation and Osteolysis Induced by Titanium Particle via Autophagy and NF-κB Signaling

Ultrasmall PtAu2 nanoclusters activate endogenous anti-inflammatory and anti-oxidative systems to prevent inflammatory osteolysis

Wear particles promote reactive oxygen species-mediated inflammation via the nicotinamide adenine dinucleotide phosphate oxidase pathway in macrophages surrounding loosened implants.

SPHK Inhibitors and Zoledronic Acid Suppress Osteoclastogenesis and Wear Particle-Induced Osteolysis.

Nanosized Alumina Particle and Proteasome Inhibitor Bortezomib Prevented inflammation and Osteolysis Induced by Titanium Particle via Autophagy and NF-B Signaling

Nano wear particles and the periprosthetic microenvironment in aseptic loosening induced osteolysis following joint arthroplasty

Bimetallic Metal-Organic Framework for Mitigating Aseptic Osteolysis

Mechanochemically Reprogrammed Interface Orchestrates Neutrophil Bactericidal Activity and Apoptosis for Preventing Implant-Associated Infection

Netrin-1 regulates ERK1/2 signaling pathway and autophagy activation in wear particle-induced osteoclastogenesis

Nano-sized Al 2 O 3 particle-induced autophagy reduces osteolysis in aseptic loosening of total hip arthroplasty by negative feedback regulation of RANKL expression in fibroblasts

NFκB Gene Silencing Inhibits Wear Particles-Induced Inflammatory Osteolysis

Molecular biological mechanisms of wear titanum particles inducing bone resorption of artificial joint

Copper modified cobalt-chromium particles for attenuating wear particle induced-inflammation and osteoclastogenesis

ZnO Nanoparticle-Infused Composite Fibers Modulate Excessive NETosis and Prolonged Inflammation in Aging

Macrophage-derived Exosomes Modulate Wear Particle-Induced Osteolysis Via Mir-3470B Targeting TAB3/NF-κB Signaling

Effect of Wnt/beta-catenin Signaling Pathway on Osteoblasts under the Action of Wear Particles

LY450139 Inhibited Ti-Particle-Induced Bone Dissolution via Suppressing Notch and NF-κB Signaling Pathways